Cargando…

Control of CAR-T cell activity in space and time: the next level of anti-tumor action

Detalles Bibliográficos
Autores principales:	Hoppstädter, Jessica, Kiemer, Alexandra K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Research Highlightḍ
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086036/ https://www.ncbi.nlm.nih.gov/pubmed/37037800 http://dx.doi.org/10.1038/s41392-023-01424-5

Ejemplares similares

Statins and Bempedoic Acid: Different Actions of Cholesterol Inhibitors on Macrophage Activation
por: Linnenberger, Rebecca, et al.
Publicado: (2021)

Glucocorticoid-induced leucine zipper (GILZ) in immuno suppression: master regulator or bystander?
por: Hoppstädter, Jessica, et al.
Publicado: (2015)

Characterization of Anti-Cancer Activities of Violacein: Actions on Tumor Cells and the Tumor Microenvironment
por: Dahlem, Charlotte, et al.
Publicado: (2022)

Thioholgamide A, a New Anti-Proliferative Anti-Tumor Agent, Modulates Macrophage Polarization and Metabolism
por: Dahlem, Charlotte, et al.
Publicado: (2020)

M2 polarization enhances silica nanoparticle uptake by macrophages
por: Hoppstädter, Jessica, et al.
Publicado: (2015)

Toll-Like Receptor 2 Release by Macrophages: An Anti-inflammatory Program Induced by Glucocorticoids and Lipopolysaccharide
por: Hoppstädter, Jessica, et al.
Publicado: (2019)

Differential cell reaction upon Toll-like receptor 4 and 9 activation in human alveolar and lung interstitial macrophages
por: Hoppstädter, Jessica, et al.
Publicado: (2010)

CAR-T: What Is Next?
por: Chen, Yi-Ju, et al.
Publicado: (2023)

Endotoxin Tolerance Acquisition and Altered Hepatic Fatty Acid Profile in Aged Mice
por: Wiesenthal, Amanda A., et al.
Publicado: (2023)

Role of Dual-Specificity Phosphatase 1 in Glucocorticoid-Driven Anti-inflammatory Responses
por: Hoppstädter, Jessica, et al.
Publicado: (2019)

Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs
por: Moghanloo, Ehsan, et al.
Publicado: (2021)

Executive Control of Actions Across Time and Space
por: Verbruggen, Frederick
Publicado: (2016)

Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors
por: Yu, Tao, et al.
Publicado: (2022)

Altered glucocorticoid metabolism represents a feature of macroph‐aging
por: Valbuena Perez, Jenny Vanessa, et al.
Publicado: (2020)

CAR models: next-generation CAR modifications for enhanced T-cell function
por: Abate-Daga, Daniel, et al.
Publicado: (2016)

Next frontiers in CAR T-cell therapy
por: Brown, Christine E, et al.
Publicado: (2016)

CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy
por: Pagotto, Sara, et al.
Publicado: (2023)

Engineering the next generation of CAR-NK immunotherapies
por: Biederstädt, Alexander, et al.
Publicado: (2021)

Amplified Host Defense by Toll-Like Receptor-Mediated Downregulation of the Glucocorticoid-Induced Leucine Zipper (GILZ) in Macrophages
por: Hoppstädter, Jessica, et al.
Publicado: (2019)

Mapping CAR T-Cell Design Space Using Agent-Based Models
por: Prybutok, Alexis N., et al.
Publicado: (2022)

Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells
por: Koristka, Stefanie, et al.
Publicado: (2019)

Next stop: space
por: Paola Catapano
Publicado: (2010)

Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells
por: Zeng, Ke, et al.
Publicado: (2023)

Infection risk in cable cars and other enclosed spaces
por: Lunati, Ivan, et al.
Publicado: (2022)

Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma
por: Petersen, Christopher T., et al.
Publicado: (2019)

Engineering Next-Generation CAR-T Cells for Better Toxicity Management
por: Andrea, Alain E., et al.
Publicado: (2020)

Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
por: Hawkins, Elizabeth R, et al.
Publicado: (2021)

CAR‐NK cells: the next wave of cellular therapy for cancer
por: Daher, May, et al.
Publicado: (2021)

CAR-T cell combination therapy: the next revolution in cancer treatment
por: Al-Haideri, Maysoon, et al.
Publicado: (2022)

Next generations of CAR-T cells - new therapeutic opportunities in hematology?
por: Tomasik, Jaromir, et al.
Publicado: (2022)

CAR-NK cell therapy for glioblastoma: what to do next?
por: Xiong, Qi, et al.
Publicado: (2023)

Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors
por: Mandriani, Barbara, et al.
Publicado: (2022)

The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018)

Surgery in the Next Space Missions
por: Pantalone, Desiree
Publicado: (2023)

Blockade of an innate immune amplifier to fight immune hyperactivation in COVID-19?
por: Kiemer, Alexandra K.
Publicado: (2020)

The mRNA-binding Protein TTP/ZFP36 in Hepatocarcinogenesis and Hepatocellular Carcinoma
por: Kröhler, Tarek, et al.
Publicado: (2019)

Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy
por: Das, Shipra, et al.
Publicado: (2023)

Teaching an old dog new tricks: next-generation CAR T cells
por: Tokarew, Nicholas, et al.
Publicado: (2018)

Adaptor CAR Platforms—Next Generation of T Cell-Based Cancer Immunotherapy
por: Arndt, Claudia, et al.
Publicado: (2020)

TGF‐β–responsive CAR‐T cells promote anti‐tumor immune function
por: Hou, Andrew J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jpr1v95khkeia57ctq0nh8hki0